Skip to main content
Government of Quebec
Institut national de santé publique du Québec
Français
FR
Home
Navigation principale
The Institute
The Institute
About us
About us
Products and services offered
Back
Contact us
Contact us
Workplaces
Back
Exit
Back
Expertise
Expertise
Information management and analysis
Information management and analysis
Deprivation
Deprivation
Indices of multiple and multidimensional deprivation
Material and Social Deprivation Index
Back
Back
Individual and community development
Individual and community development
Perinatal and early childhood
Perinatal and early childhood
From Tiny Tot to Toddler
Back
Back
Lifestyles
Lifestyles
Alimentation
Alimentation
Health-promoting environments
Back
Back
Psychoactive substances, tobacco and gambling
Psychoactive substances, tobacco and gambling
Drugs and medicines
Drugs and medicines
Opioid overdoses
Back
Tobacco and electronic cigarettes
Tobacco and electronic cigarettes
Science Watch : Tobacco Control
Back
Back
Infectious diseases
Infectious diseases
Respiratory infectious diseases
Respiratory infectious diseases
Données des virus respiratoires
COVID-19 (coronavirus)
Back
Prevention and control of healthcare-associated infections
Prevention and control of healthcare-associated infections
Nosocomial infections
Back
Travel-health
Travel-health
Health tips for travellers
Back
Zoonoses and emerging diseases
Zoonoses and emerging diseases
Diseases transmitted by ticks
Back
Back
Occupational health
Occupational health
Work-related respiratory diseases
Work-related respiratory diseases
Asbestos
Back
Psychosocial risks in the workplace
Psychosocial risks in the workplace
Let's get started
Back
Back
Indigenous Health
Indigenous Health
Research Monitoring
Research Monitoring
Methodology for Indigenous Health Research Monitoring
Back
Nunavik Inuit Health Survey 2004
Back
Environmental Health
Environmental Health
Air quality
Air quality
Indoor air
Back
Back
Safety, violence and injury prevention
Safety, violence and injury prevention
Community safety promotion
Community safety promotion
Methods and tools
Back
Prevention of interpersonal violence
Prevention of interpersonal violence
Sexual Violence
Rapport québécois sur la violence et la santé
Back
Back
Exit
Back
Services
Services
Centre de toxicologie du Québec
Centre de toxicologie du Québec
About the CTQ
About the CTQ
Contact us
Back
Services
Services
Test catalog
Analysis request forms
Shipping samples
PayPal Bill Payment
Back
External quality assessment schemes
External quality assessment schemes
AMAP: AMAP Ring Test for Persistent Organic Pollutants in Human Serum
Creatinine: Interlaboratory Comparison Program for Measurement of Serum Creatinine
OSEQAS: External Quality Assessment Scheme for Organic Substances in Urine
PCI: Interlaboratory Comparison Program for Metals in Biological Matrices
QMEQAS: Quebec Multielement External Quality Assessment Scheme
Back
Back
Infectious diseases
Infectious diseases
Blood-Borne Infection Risk Assessment Unit
Blood-Borne Infection Risk Assessment Unit
Risk Assessment Process
Rights and Responsibilities
Back
Back
Exit
Back
Publications
Publications
Publications
Subscribe to INSPQ's mailing lists
Exit
Back
Surveys
Surveys
Respiratory viruses survey
Respiratory viruses survey
Complete the survey (period from October 19 to 25, 2025)
Back
Exit
Back
Danger page
Search
Search by keywords
Content type
Content type
Data
Internship
Laboratory analysis
News
Newsletter
Page
Publication
Tiny Tot
Training
Caroline Sirois
Publications
INSPQ
2025
Vieillissement en santé : Portrait des médicaments potentiellement inappropriés chez les personnes aînées au Québec de 2012 à 2022
Pandémie de COVID-19 : répercussions sur l’usage de médicaments et la polypharmacie
Vieillissement en santé : Portrait de la polypharmacie chez les personnes aînées au Québec de 2000 à 2022
2024
Vieillissement en santé : Surveillance de la qualité et de la complexité des pharmacothérapies chez les aînés québécois
2023
Portrait de la polypharmacie chez les aînés québécois atteints d’insuffisance cardiaque entre 2000 et 2019
2022
Impact des maladies chroniques sur la prescription des antibiotiques selon les guides cliniques dans la communauté
Impact des maladies chroniques sur les taux d’utilisation des antibiotiques dans la communauté
2021
Portrait de la polypharmacie chez les aînés québécois atteints de maladie pulmonaire obstructive chronique entre 2000 et 2015
2020
Portrait de la polypharmacie chez les aînés québécois entre 2000 et 2016
L’effet combiné de la multimorbidité et des troubles mentaux sur les admissions fréquentes à l’urgence chez les adultes québécois
2019
Multimorbidité : les enjeux liés à la surveillance populationnelle - Actes de conférence
La prévalence de la multimorbidité au Québec : portrait pour l’année 2016-2017
Utilisation des médicaments potentiellement inappropriés chez les aînés québécois présentant des maladies chroniques ou leurs signes précurseurs : portrait 2014-2015
Utilisation communautaire d’antibiotiques – Projet de démonstration à partir des données du Système intégré de surveillance sur les maladies chroniques du Québec
2017
Polypharmacie et déprescription : des réalités cliniques et de recherche jusqu’à la surveillance
2015
Utilisation des médicaments antidiabétiques et cardioprotecteurs chez les aînés diabétiques au Québec en 2011-2012
2010
Utilisation des antidiabétiques oraux et des médicaments cardioprotecteurs par les aînés québécois atteints de diabète de type 2, de 1998 à 2002
Scientific papers
2025
Combined impact of the COVID-19 pandemic and the number of comorbidities on community antibiotic utilisation rates: a population-based retrospective cohort study using linked health administrative data in Quebec, Canada
Patterns and determinants of statin prescribing and discontinuation in individuals aged 80 and older: a ten-year population-based cohort study
Trends in medication use during the COVID-19 pandemic in Quebec, Canada
Guidelines and Best Practices for the Use of Targeted Maximum Likelihood and Machine Learning When Estimating Causal Effects of Exposures on Time-To-Event Outcomes
Author's reply : "The importance of properly specifying your target trial emulation: commentary on Mésidor et al."
Trends in COPD severe exacerbations, and all-cause and respiratory mortality, before and after implementation of newer long-acting bronchodilators in a large population-based cohort
2024
Cluster B personality disorders and psychotropic medications: a focused analysis of trends and patterns across sex and age groups
Traditional methods hold their ground against machine learning in predicting potentially inappropriate medication use in older adults
Traditional methods hold their ground against machine learning in predicting potentially inappropriate medication use in older adults
Medication Use Around the Diagnosis of Alzheimer's Disease: A Commentary on the Study by Liau et al
Medication Use Around the Diagnosis of Alzheimer's Disease: A Commentary on the Study by Liau et al
A comparative analysis of medication counting methods to assess polypharmacy in medico-administrative databases
Multimorbidity prevalence and health outcome prediction: assessing the impact of lookback periods, disease count, and definition criteria in health administrative data at the population-based level
Effect of statin use for the primary prevention of cardiovascular disease among older adults: A cautionary tale concerning target trials emulation
Association between number of medications and indicators of potentially inappropriate polypharmacy: a population-based cohort of older adults in Quebec, Canada
10-Year Multimorbidity Trajectories in Older People Have Limited Benefit in Predicting Short-Term Health Outcomes in Comparison to Standard Multimorbidity Thresholds: A Population-Based Study
Psychotropic medication use pre and post-diagnosis of cluster B personality disorder: a Quebec's health services register cohort
2023
Psychiatric and non-psychiatric polypharmacy among older adults with schizophrenia: Trends from a population-based study between 2000 and 2016
Polypharmacy among older individuals with heart failure: trends between 2000 and 2017 in the province of Quebec, Canada
2022
Chronic diseases and compliance with provincial guidelines for outpatient antibiotic prescription in cases of otitis media and respiratory infections: a population-based study of linked data in Quebec, Canada, 2010-2017
Chronic diseases and variations in rates of antimicrobial use in the community: a population-based analysis of linked administrative data in Quebec, Canada, 2002-2017
The 5-year longitudinal diagnostic profile and health services utilization of patients treated with electroconvulsive therapy in Quebec: a population-based study
Exploring the associations between polypharmacy and COVID-19-related hospitalisations and deaths: a population-based cohort study among older adults in Quebec, Canada
Trends in benzodiazepine and alternative hypnotic use in relation with multimorbidity among older adults in Quebec, Canada
2021
Economic Evaluations of Interventions to Optimize Medication Use in Older Adults with Polypharmacy and Multimorbidity: A Systematic Review
Potentially inappropriate medications in older individuals with diabetes: A population-based study in Quebec, Canada
2020
Chronic respiratory disease should be considered when interpreting indicators of community antimicrobial use in people over 65 years old
Polypharmacy and Pharmacological Treatment of Diabetes in Older Individuals: A Population-Based Study in Quebec, Canada
2019
Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health
Polypharmacy among Older Individuals with COPD: Trends between 2000 and 2015 in Quebec, Canada
Combined impacts of multimorbidity and mental disorders on frequent emergency department visits: a retrospective cohort study in Quebec, Canada
Opioid prescribing and dispensing: Experiences and perspectives from a survey of community pharmacists practising in the province of Quebec
2018
Precision on the Scope on the Combined Comorbidity Index Published in: Validation of the Combined Comorbidity Index of Charlson and Elixhauser to Predict 30-Day Mortality Across ICD-9 and ICD-10
Validation of the Combined Comorbidity Index of Charlson and Elixhauser to Predict 30-Day Mortality Across ICD-9 and ICD-10
Association Between Anticholinergic Drug Use and Health-Related Quality of Life in Community-Dwelling Older Adults.
2017
Polypharmacy in multimorbid older adults: protocol for a systematic review.
Le Système intégré de surveillance des maladies chroniques du Québec (SISMACQ), une approche novatrice
2014
Quebec Integrated Chronic Disease Surveillance System (QICDSS), an innovative approach
Association between nutrition and the evolution of multimorbidity: the importance of fruits and vegetables and whole grain products
Understanding the evolution of multimorbidity: evidences from the North West Adelaide Health Longitudinal Study (NWAHS)
Le modèle québécois de surveillance des maladies chroniques basé sur l'utilisation des données médico-administratives jumelées.
2013
Medication Use in a Population-Based Cohort of Elderly Individuals with Diabetes in Quebec.
Association between age and the initiation of antihypertensive, lipid lowering and antiplateletet medications in elderly individuals newly treated with antidiabetic drugs
2009
The benefit of aspirin therapy in type 2 diabetes: what is the evidence?
2008
Underuse of cardioprotective treatment by the elderly with type 2 diabetes
Suboptimal use of cardioprotective drugs in newly treated elderly individuals with type 2 diabetes
2007
Le modèle québécois de surveillance des maladies chroniques basé sur l'utilisation des données médico-administratives jumelées
Others
2013
Cost trends of potentially inappropriate medications among older adults between 2012 and 2021 in Quebec, Canada: a population-based repeated cross-sectional study
Government of Quebec
Government of Quebec
